Credit Suisse Ag Qiagen N.V. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$35.55 - $43.57 $4.14 Million - $5.08 Million	-116,551 Reduced 15.29%	645,717 $28 Million
Q3 2023 Nov 13, 2023	SELL	$39.13 - $47.24 $1.13 Million - $1.36 Million	-28,853 Reduced 3.65%	762,268 $30.9 Million
Q2 2023 Aug 11, 2023	BUY	$43.93 - $46.76 $1.1 Million - $1.18 Million	25,143 Added 3.28%	791,121 $35.6 Million
Q1 2023 May 10, 2023	SELL	$45.29 - $50.76 $2.05 Million - $2.29 Million	-45,199 Reduced 5.57%	765,978 $35.2 Million
Q4 2022 Feb 13, 2023	SELL	$41.91 - $50.48 $3.71 Million - $4.47 Million	-88,502 Reduced 9.84%	811,177 $40.5 Million
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $2.79 Million - $3.44 Million	68,171 Added 8.2%	899,679 $37.1 Million
Q2 2022 Aug 12, 2022	BUY	$42.98 - $49.77 $5.13 Million - $5.95 Million	119,458 Added 16.78%	831,508 $39.2 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $5.22 Million - $6.71 Million	123,566 Added 21.0%	712,050 $34.9 Million
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $7.02 Million - $7.83 Million	-138,659 Reduced 19.07%	588,484 $32.7 Million
Q3 2021 Nov 12, 2021	SELL	$46.55 - $56.83 $33.1 Million - $40.4 Million	-711,077 Reduced 49.44%	727,143 $37.6 Million
Q2 2021 Aug 16, 2021	SELL	$46.28 - $52.75 $23.1 Million - $26.4 Million	-499,543 Reduced 25.78%	1,438,220 $71 Million
Q1 2021 May 14, 2021	BUY	$46.25 - $56.02 $48.2 Million - $58.3 Million	1,041,541 Added 116.21%	1,937,763 $94.4 Million
Q4 2020 Feb 12, 2021	SELL	$46.09 - $54.74 $82.1 Million - $97.5 Million	-1,781,324 Reduced 66.53%	896,222 $47.4 Million
Q3 2020 Nov 13, 2020	SELL	$42.51 - $52.42 $324 Million - $399 Million	-7,611,742 Reduced 73.98%	2,677,546 $140 Million
Q2 2020 Aug 12, 2020	BUY	$39.49 - $44.36 $177 Million - $199 Million	4,493,594 Added 77.53%	10,289,288 $440 Million
Q1 2020 May 13, 2020	BUY	$33.17 - $41.6 $117 Million - $147 Million	3,526,474 Added 155.4%	5,795,694 $241 Million
Q4 2019 Feb 12, 2020	BUY	$25.41 - $43.1 $26 Million - $44 Million	1,021,835 Added 81.92%	2,269,220 $76.7 Million
Q3 2019 Nov 12, 2019	BUY	$32.73 - $40.81 $5.52 Million - $6.88 Million	168,531 Added 15.62%	1,247,385 $41.1 Million
Q2 2019 Aug 14, 2019	SELL	$35.73 - $41.39 $4.25 Million - $4.93 Million	-119,007 Reduced 9.93%	1,078,854 $43.7 Million
Q1 2019 May 14, 2019	BUY	$33.78 - $40.68 $3.54 Million - $4.27 Million	104,913 Added 9.6%	1,197,861 $48.7 Million
Q4 2018 Feb 13, 2019	SELL	$32.65 - $37.95 $2.82 Million - $3.28 Million	-86,413 Reduced 7.33%	1,092,948 $37.7 Million
Q3 2018 Nov 13, 2018	SELL	$35.99 - $39.39 $1.31 Million - $1.43 Million	-36,305 Reduced 2.99%	1,179,361 $44.7 Million
Q2 2018 Aug 14, 2018	SELL	$31.23 - $37.47 $1.16 Million - $1.39 Million	-37,136 Reduced 2.96%	1,215,666 $44 Million
Q1 2018 May 15, 2018	BUY	$31.01 - $34.72 $2.21 Million - $2.47 Million	71,257 Added 6.03%	1,252,802 $40.5 Million
Q4 2017 Feb 14, 2018	SELL	$30.68 - $35.37 $1.26 Million - $1.46 Million	-41,213 Reduced 3.37%	1,181,545 $36.5 Million
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $6.43 Million - $6.83 Million	207,203 Added 20.4%	1,222,758 $38.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,015,555	1,015,555 $34.1 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$192 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$41.6 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

796K
Shares

$35.6 Million
3.21% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.86 Million
0.01% of portfolio
Bdl Capital Management Paris, I0

88.8K
Shares

$3.97 Million
3.33% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.2B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account